<DOC>
	<DOCNO>NCT00139724</DOCNO>
	<brief_summary>To evaluate efficacy tolterodine extend release formulation compare immediate release formulation subject symptoms overactive bladder</brief_summary>
	<brief_title>Evaluate Efficacy Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Tolterodine Tartrate</mesh_term>
	<criteria>Subjects diagnosis overactive bladder . Subjects significant stress incontinence determine investigator . Subjects recurrent urinary tract infection define treated UTI ; 5 time last year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>